The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
Open accessAbstract
Background: Parkinson’s disease (PD) is the second most prevalent movement disorder characterized by up to 80% loss of dopamine (DA) neurons and accumulation of Lewy body deposits composed of α-synuclein (α-syn). Accumulation of α-syn is associated with microglial activation, leading to a pro-inflammatory environment linked with the pathogenesis of PD. Along with microglia, CD4 and CD8 T cells are observed in SNpc. The contribution of T-cells to PD development remains unclear with studies demonstrating that they may mediate neurodegeneration or act in a neuroprotective manner. Methods: Here, we assessed the contribution of T cells to PD neurodegeneration using an adeno-associated virus (AAV) coding human wild-type α-syn or GFP injected into the substantia nigra pars compacta (SNpc) in T cell deficient (athymic nude) and T cell competent (heterozygous) rats. The rats were behaviorally assessed with cylinder test to test paw bias. Following behavior testing, brains were collected and analyzed for markers of dopamine neuron, microglial activation, T cells, and α-syn expression. Results: Injection of AAV9-α-syn unilaterally into the SN of T cell competent rats resulted in a significant paw bias in comparison to the controls at 60 days post-injection. Conversely, T cell-deficient rats injected with AAV9-α-syn showed no deficit in paw bias. As expected, injected T cell competent rats demonstrated a significant increase in microglial activation (MHCII staining) as well as significant dopaminergic neuron loss. In contrast, the T cell-deficient counterparts did not show a significant increase in microglial activation or significant neuron loss compared to the control animals. We also observed CD4 and CD8 T cells in SNpc following microglial MHCII expression and dopaminergic neuron loss. The time course of T cell entry correlates with upregulation of MHCII and the peak loss of TH+ cells in the SNpc. Conclusion: These data demonstrate that T cell infiltration and microglial upregulation of MHCII are involved in α-synuclein-mediated DA neuron loss in this rat model of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 a-d Representative photomicrographs of α-syn33 (marker for oligomeric α-synuclein) staining. e-h Representative photomicrographs of α-sy211 (marker for oligomeric α-synuclein) staining. a, e T cell deficient (nude) rats injected with AAV9-GFP (n = 10); b, f T cell deficient rats injected with AAV9-human α-synuclein (αsyn) (n = 10); c, g T cell competent (heterozygous nude) rats injected with AAV9-GFP (n = 10); d, h T cell competent rats injected with AAV9-human α-synuclein (n = 10). i Bar graph shows the expression level of α-synuclein oligomers by staining with anti-αsyn211 antibody in SNpc region when examined 2-month post-surgery. Both nude rats and heterozygous nude rats injected with AAV9- α-syn showed similar range of α-synuclein oligomer expression with respect to the dopamine neurons in the SNpc region. j Bar graph shows the area units of the α-syn oligomer expression when stained with the α-syn33 antibody (donation from Dr. Rakez Kayed [28]). Like the α-syn211 staining, no significant difference was observed in the expression level of α-syn oligomers in the two groups treated with AAV9-α-syn with respect to the dopamine neurons in the SNpc region. k Bar graph shows the number of α-syn oligomers (stereology counting) in the SNpc region with respect to the dopamine neurons. Like the NearCYTE software comparison, stereology counting of α-syn oligomers did not show any significant difference between both groups treated with AAV9-α-syn. The bars in the graph represent mean ± standard error of the mean](https://figures.cochat.ai/paper-figures/88839e3b17164590868cf351a7ab485b/t-cell-infiltration-and-upregulation-of-mhcii-in-microglia-leads-to-accelerated-figure-4.jpg)

![Fig. 6 a Bar graph shows the percentage area of TH+ positive staining in SNpc by comparing the injected ipsilateral to the untreated contralateral side in heterozygous nude rats at four timepoints (2 weeks, 4 weeks, 6 weeks, 8 weeks) injected with AAV9-GFP (n = 3) or AAV9-α-syn (n = 5). A significant difference (Two-way ANOVA p < 0.05; treatment: F (1, 24) = 243.8, p < 0.01; timepoint: F (3, 24) = 55.62, p < 0.01; post hoc analysis: Tukey’s multiple comparison test) of percentage positive cells was observed between the heterozygous nude rats injected with αsyn when compared to GFP injected controls at 4 (30 days), 6 (45 days), and 8 (60 days) weeks timepoint. A progressive loss of dopamine neurons was observed in heterozygous nude rats injected with AAV9-α-syn when compared at 4, 6, and 8 weeks timepoint. b Bar graph shows the area units of the α-syn oligomer expression by staining with the α-syn33 antibody (donation from Dr. Rakez Kayed [29]) of the heterozygous nude rats injected with AAV9-GFP (n = 3) or AAV9-α-syn (n = 5) at four different timepoints. At 2 weeks (14 days) α-syn expression begins to be observed and then increases further at 4 weeks (30 days). No significant difference was observed in the expression level of α-syn oligomers in the heterozygous nude rats treated with AAV9-α-syn normalized to the dopamine neurons in the SNpc region at 4, 6, and 8 weeks timepoint. c Bar graph shows the area units for Iba1 staining for microglia in heterozygous nude rats injected with either AAV9-GFP (n = 3) or AAV9-α-syn (n = 5) in the SNpc region at four different timepoint. Heterozygous nude rats injected with AAV9-α-syn showed increased number of Iba1 cells in SNpc region when compared to GFP injected controls at 4, 6, and 8 weeks (Two-way ANOVA p < 0.0001; treatment: F (1, 24) = 36.01, p < 0.0001; post hoc analysis: Tukey’s multiple comparison test). No significant difference was observed between heterozygous nude rats injected with AAV9-αsyn at 4, 6, and 8 weeks timepoint. d Bar graph shows the area units for MHC II staining for activated microglia in heterozygous nude rats injected with either AAV9-GFP (n = 3) or AAV9-α-syn (n = 5) at four different timepoints. The microglia express MHCII only in the heterozygous nude rats injected with AAV9-α-syn in SNpc region gradually increasing from 4 weeks to 8 weeks (Two-way ANOVA p < 0.001; treatment: F (1, 24) = 60.63, p < 0.0001; timepoint: F (3, 24) = 12.43, p < 0.0001; post hoc analysis: Tukey’s multiple comparison test). The MHCII positive microglia was observed higher in 8 weeks timepoint when compared to the 6 and 4 weeks coinciding with dopamine neuron loss in SNpc. e Bar graph shows the number of CD4 T cells in the injected side of the SNpc region in heterozygous nude rats at four different timepoints. A significant difference in the number of CD4 T cells was observed in heterozygous nude rats injected with AAV9-αsyn when compared to GFP injected controls at 4, 6, and 8 weeks timepoint (Two-way ANOVA p < 0.001; treatment: F (1, 23) = 205, p < 0.0001; timepoint: F (3, 23) = 86.33, p < 0.0001; post hoc analysis: Tukey’s multiple comparison test). Also, a gradual increase in the number of CD4 T cells was observed in heterozygous nude rats injected with AAV9-α-syn as time increases. f Bar graph shows the number of CD8 T cells in the injected side of the SNpc region in heterozygous nude rats at four different timepoints. A significant difference in the number of CD8 T cells was observed in heterozygous nude rats injected with AAV9-αsyn when compared to GFP-injected controls at 4, 6, and 8 weeks timepoint (two-way ANOVA p < 0.001; treatment: F (1, 23) = 396.7, p < 0.0001; timepoint: F (3, 23) = 190.7, p < 0.0001; post hoc analysis: Tukey’s multiple comparison test). Also, a gradual increase in the number of CD8 T cells was observed in heterozygous nude rats injected with AAV9-α-syn as time increases. *p < 0.05, **p < 0.001 when compared to GFP injected controls at a given timepoint; #p < 0.05 when compared to α-syn injected heterozygous nude rats at the previous timepoint. The bars in the graph represent mean ± standard error of the mean. g A representative figure explaining the timeline of dopamine neuron loss (TH) coinciding with microglial MHCII activation and CD4 and CD8 T cells infiltration along with Iba1 microglia and α-syn33 oligomer expression attaining stable expression after 4 weeks of AAV9-α-syn injection. The timeline for each immunohistochemistry staining represented here is percentage of expression attaining 100% either at 0 or 8 weeks (60 days)](https://figures.cochat.ai/paper-figures/007e5d24b7fd4eaaaa0bbae59606707a/t-cell-infiltration-and-upregulation-of-mhcii-in-microglia-leads-to-accelerated-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, MHCII expression precedes and regulates dopaminergic neurodegeneration in the substantia nigra [94,95,96].”
From Beyond Activation: Characterizing Microglial Functional Phenotypes (2021) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Intriguingly, T cell deficiency can decrease the loss of dopamine neurons and microglial major histocompatibility complex II expression.90”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Microglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
The journal of clinical investigation
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92394-9 · Cited by 1,198
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Cited by
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
Chen, X., Firulyova, M., Manis, M., Herz, J., Smirnov, I., Aladyeva, E., Wang, C., Bao, X., Finn, M. B., Hu, H., et al. (2023) · Nature · doi:10.1038/s41586-023-05788-0 · Cited by 609
Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
Badanjak, K., Fixemer, S., Smajić, S., Skupin, A., & Grünewald, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094676 · Cited by 276
Beyond Activation: Characterizing Microglial Functional Phenotypes
Lier, J., Streit, W. J., & Bechmann, I. (2021) · Cells · doi:10.3390/cells10092236 · Cited by 324
Metadata
- Authors
- Subbarayan, M. S., Hudson, C., Moss, L. D., Nash, K. R., & Bickford, P. C.
- Affiliations
- University of South Florida (US)
- James A. Haley Veterans' Hospital (US)
- Corresponding author
- Bickford, Paula C.
- Venue
- Journal of Neuroinflammation
- Published
- 2020-08-15
- Volume
- 17
- Issue
- 1
- Pages
- 242-242
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC7429710
- OpenAlex
- W3049140851
- Cited by
- 107
- References
- 48
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 25 · 2023: 16 · 2022: 18 · 2021: 19 · 2020: 6
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (I01BX000231, IKBX004214)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, alpha-synuclein, T cell infiltration, dopaminergic neuron loss, substantia nigra pars compacta, microglial activation, neuroinflammation, CD4+ T cells, CD8+ T cells, athymic nude rats, Lewy bodies, neurodegeneration
- MeSH terms
- Animals, Cells, Cultured, Disease Models, Animal, Male, Neurons, Parkinson Disease, Rats, Nude, Substantia Nigra, T-Lymphocytes, Up-Regulation, Microglia, Rats, alpha-Synuclein, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease. https://app.cochat.ai/papers/10.1186/s12974-020-01911-4
- The paper
- Subbarayan, M. S., Hudson, C., Moss, L. D., Nash, K. R., & Bickford, P. C. (2020). T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-020-01911-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.